Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta-analyses
<p><strong>Objective</strong> To assess the associations between statins and adverse events in primary prevention of cardiovascular disease and to examine how the associations vary by type and dosage of statins.</p> <p><strong>Design</strong> Systematic rev...
Autors principals: | Cai, T, Abel, L, Langford, O, Monaghan, G, Aronson, JK, Stevens, RJ, Lay-Furrie, S, Koshiaris, C, McManus, RJ, Hobbs, FDR, Sheppard, JP |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
BMJ Publishing Group
2021
|
Ítems similars
-
The association between antihypertensive treatment and serious adverse events by age and frailty: a cohort study
per: Sheppard, JP, et al.
Publicat: (2023) -
Methods for meta-analysis of pharmacodynamic dose–response data with application to multi-arm studies of alogliptin
per: Langford, O, et al.
Publicat: (2016) -
Spontaneous reporting to regulatory authorities of suspected adverse drug reactions to COVID-19 vaccines over time: the effect of publicity
per: Ferner, RE, et al.
Publicat: (2022) -
Predicting the risk of falls in patients with an indication for antihypertensive treatment: development and validation of the stratify-falls prediction model
per: Archer, L, et al.
Publicat: (2022) -
Low-dose spironolactone and cardiovascular outcomes in moderate stage chronic kidney disease: a randomized controlled trial
per: Hobbs, FDR, et al.
Publicat: (2024)